Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Bolt Biotherapeutics
Biotech
Biotechs cut pipeline prospects to focus on priority programs
Preparing for a prolonged bear market, a raft of biotechs have decided candidates that looked good a few months ago are now an extravagance.
Nick Paul Taylor
Aug 11, 2022 9:43am
Bolt cans candidate over toxicity, pauses work to extend runway
Aug 11, 2022 7:50am
Genmab joins with Bolt to develop bispecific immune stimulators
Jun 2, 2021 8:00am
Bolt Biotherapeutics strikes a major upsized $230M IPO
Feb 5, 2021 9:05am
Bolt Bio preps trials of immune-stimulating cancer drug
Nov 11, 2019 9:36am